Shares of ImmunoPrecise Antibodies Ltd. (CVE:IPA – Get Free Report) traded up 0.8% during trading on Friday . The stock traded as high as C$6.70 and last traded at C$6.50. 19,980 shares traded hands during trading, an increase of 3% from the average session volume of 19,376 shares. The stock had previously closed at C$6.45.
ImmunoPrecise Antibodies Trading Up 0.8 %
The company has a market capitalization of C$162.08 million and a PE ratio of -7.30. The company has a debt-to-equity ratio of 1.70, a quick ratio of 4.29 and a current ratio of 5.06. The business has a fifty day moving average price of C$6.50 and a 200 day moving average price of C$6.50.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes.
See Also
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Calculate Return on Investment (ROI)
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Top-Performing Non-Leveraged ETFs This Year
- Which Wall Street Analysts are the Most Accurate?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
